Anti-HDAC5 (phospho S498) antibody

Name Anti-HDAC5 (phospho S498) antibody
Supplier Abcam
Catalog ab47283
Prices $384.00
Sizes 100 µg
Host Rabbit
Clonality Polyclonal
Isotype IgG
Applications WB IHC-P ELISA
Species Reactivities Human, Mouse, Rat
Antigen A synthesized phosphopeptide derived from human HDAC5 around the phosphorylation site of Serine498 (T-Q-SP-S-P)
Description Rabbit Polyclonal
Gene HDAC5
Conjugate Unconjugated
Supplier Page Shop

Product images


Product References

Regulation by phosphodiesterase isoforms of protein kinase A-mediated attenuation - Regulation by phosphodiesterase isoforms of protein kinase A-mediated attenuation

Haworth RS, Cuello F, Avkiran M. Basic Res Cardiol. 2011 Jan;106(1):51-63.

AMP-activated protein kinase regulates beta-catenin transcription via histone - AMP-activated protein kinase regulates beta-catenin transcription via histone

Zhao JX, Yue WF, Zhu MJ, Du M. J Biol Chem. 2011 May 6;286(18):16426-34.

Sirtuin 1 (SIRT1) deacetylase activity is not required for mitochondrial - Sirtuin 1 (SIRT1) deacetylase activity is not required for mitochondrial

Philp A, Chen A, Lan D, Meyer GA, Murphy AN, Knapp AE, Olfert IM, McCurdy CE, Marcotte GR, Hogan MC, Baar K, Schenk S. J Biol Chem. 2011 Sep 2;286(35):30561-70.

A novel kinase inhibitor establishes a predominant role for protein kinase D as a - A novel kinase inhibitor establishes a predominant role for protein kinase D as a

Monovich L, Vega RB, Meredith E, Miranda K, Rao C, Capparelli M, Lemon DD, Phan D, Koch KA, Chapo JA, Hood DB, McKinsey TA. FEBS Lett. 2010 Feb 5;584(3):631-7.

Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts - Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts

Konno T, Chen D, Wang L, Wakimoto H, Teekakirikul P, Nayor M, Kawana M, Eminaga S, Gorham JM, Pandya K, Smithies O, Naya FJ, Olson EN, Seidman JG, Seidman CE. Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18097-102. doi:

Loss of the Ca2+/calmodulin-dependent protein kinase type IV in dopaminoceptive - Loss of the Ca2+/calmodulin-dependent protein kinase type IV in dopaminoceptive

Bilbao A, Parkitna JR, Engblom D, Perreau-Lenz S, Sanchis-Segura C, Schneider M, Konopka W, Westphal M, Breen G, Desrivieres S, Klugmann M, Guindalini C, Vallada H, Laranjeira R, de Fonseca FR, Schumann G, Schutz G, Spanagel R. Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17549-54. doi: